Drug Resistance Inhibition in Treating Women With Recurrent or Metastatic Breast Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Robert W. Carlson, MD
Stanford University
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Veterans Affairs Medical Center - Palo Alto
Palo Alto, California, United States
- Stanford University Medical Center
Stanford, California, United States
- Hunterdon Regional Cancer Program
Flemington, New Jersey, United States
- Kimball Medical Center
Lakewood, New Jersey, United States
- Fox Chase Cancer Center at Virtua-Memorial Hospital Burlington County
Mount Holly, New Jersey, United States
- Cancer Institute of New Jersey
New Brunswick, New Jersey, United States
- St. Francis Medical Center
Trenton, New Jersey, United States
- Albert Einstein Comprehensive Cancer Center
The Bronx, New York, United States
- Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 14 Aug 1997
- Primary completion
- 30 Nov 2003
- Completion
- —
- Last update posted
- 7 Jun 2023
- Registered enrollment
- 36
- Registry id
- NCT00002826
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.